Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1697 (LINC01697)
- Target
- LINC01697
- Molecular classification
- Long intergenic non-coding RNA (lincRNA), Non-coding RNA
01
Overview
LINC01697 (long intergenic non-protein coding RNA 1697) is a human long intergenic non-coding RNA gene. LincRNAs such as LINC01697 belong to a class of regulatory RNAs that do not encode proteins but can modulate cellular gene expression at multiple levels, including chromatin modification, transcription, and RNA stability. LINC01697 has been identified in transcriptomic studies as differentially expressed in certain cancers, and its expression has been associated with patient prognosis and disease risk, particularly in lung squamous cell carcinoma. LINC01697 likely acts by influencing the expression of adjacent or distant genes, consistent with the regulatory roles described for lincRNAs in general. While altered LINC01697 levels may serve as a biomarker in oncology, there are currently no direct therapeutics targeting this molecule. Note: LINC01697 should not be confused with protein-coding targets or receptors. Its main importance lies in biomarker discovery and the emerging understanding of lncRNA regulatory networks in human disease.
- Other names
- LINC01697
02
Biological functions
Transcriptional regulationModulation of gene expressionPossible role in cell proliferation and malignant transformation
03
Disease associations
Cancer (including lung squamous cell carcinoma, other unspecified malignancies)
04
Safety considerations
As it is not a direct therapeutic target, safety considerations specific to LINC01697 modulation are not documented. However, its functional roles in gene regulation suggest that targeting lincRNAs in general could raise challenges related to specificity and off-target effects.
05
Biomarkers
LINC01697 expression (as a component of lincRNA signatures for patient risk stratification and prognosis in cancer)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1697 (LINC01697).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1697 (LINC01697).